Melbourne. Australia’s largest Phase 1 Clinical Trial Unit
Located within The Alfred Hospital precinct, our Melbourne site offers unmatched capacity, specialist expertise, and hospital-grade safety for early-phase trials, from healthy volunteer to patient studies.
Purpose-built for early-phase success
Nucleus Network Melbourne is the country’s largest and most experienced early-phase clinical trial facility and is purpose-designed for First-in-Human and clinical pharmacology studies.
Co-located with the Alfred Hospital, the unit combines academic access, tertiary medical infrastructure, and dedicated early-phase teams to deliver fast, high-quality trial execution. With over 20 years of experience and a track record across 1,500+ global studies, sponsors trust our Melbourne site to deliver results safely and efficiently.
Fast facts
110
Beds
Alfred Hospital, Melbourne
Co-Location
CNS, metabolic, oncology, vaccines, renal
Therapeutic Expertise
FIH, SAD/MAD, food effect, QTc, biosimilars
Trial Types
FDA- and EMA-inspected
Certifications
200k+ national database
Participant Access
Australia’s premier destination for early-phase trials
- Located in one of Australia’s top biomedical precincts
- Access to leading academic and clinical experts
- Integrated with onsite radiology, pharmacy, and emergency support
- Direct support from Nucleus Network’s executive, regulatory, and scientific leadership
- Rapid ethics approvals and CTN activation within 6–8 weeks*
- Significant R&D cost advantages under Australia’s 43.5% tax rebate program*
Expertise across diverse therapeutic areas
- Central Nervous System (CNS)
- Metabolic & Endocrine (e.g. diabetes, obesity)
- Oncology (early-phase)
- Vaccines & Infectious Diseases
- Cardiology
- Gastroenterology
- Immunology
What sponsors can expect at our Melbourne site
- Dedicated First-in-Human teams
- Onsite telemetry, imaging, ECG, lab, and pharmacy services
- 24/7 medical oversight and access to intensive care
- Strong operational links to Brisbane and Minneapolis units
- Audit-ready documentation and SOPs aligned to FDA/EMA standards
- Direct support from Nucleus Network’s executive, regulatory, and scientific leadership
Advance your study in Melbourne
From FIH design to global data delivery, our Melbourne site offers the expertise, scale, and safety you need. Let’s accelerate your next trial and bring new therapies to life, faster.
